KLK3 and prostate carcinoma: Philip et al. [7], who studied whether a DRE is necessary for the diagnosis and clinical staging of early prostate cancer, found no correlation between DRE, biopsy findings and pathological staging, and decided that a DRE may not be essential for patients with a PSA level of 2.5-10 ng/mL.